[Diagnostic value of copper and magnesium in hemolymphopathies and solid tumors].
The value and development of the copper and magnesium have been examined in thirty-four patients whose eighteen were affected by malignant lymphomas (9 L.H. and 9 non-H.), fourteen by solid tumors and two by acute leukemias. Our results prove clearly a manifest increase of the copper in the lymphomas' patients, especially in the Hodgkin's disease, and in none patients a decrease. Analogous trend has been found in the 71% of the patients with solid tumors. Scarcely significant are the results obtained in the acute leukemias. Contrary to copper, the values of the magnesium are nothing at all expressive for a diagnostic "dépistage"; a light increase of the metal is observed only in the 55% of the lymphomas non-H., while in the cancers the values are very variable. Our results confirm what other Authors have already referred, i.e. the copper's value is of a large aiding for the determination and the valuation of the diseases' activity in the above related conditions.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003300:Copper / Q000097:blood*; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis; D006801:Humans; D007938:Leukemia / Q000175:diagnosis; D008223:Lymphoma / Q000175:diagnosis*; D008274:Magnesium / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000175:diagnosis*; D013223:Statistics as Topic
D003300:Copper; D008274:Magnesium
Validità diagnostica del Cu e del Mg nelle emolinfopatie e nei tumori solidi.